|
Market Closed -
Sao Paulo
23:53:36 09/10/2026 +04
|
5-day change | 1st Jan Change | ||
| 74.27 BRL | -0.71% |
|
+3.15% | +12.60% |
| 10-12 | Amgen's Q3 Results Should Reflect Continued Commercial Momentum, BofA Securities Says | MT |
| 10-12 | BofA Securities Adjusts Amgen Price Target to $328 From $317, Maintains Underperform Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AMGEN INC. | Other Pharmaceuticals | -0.71% | +3.15% | +12.60% | +30.55% | +81.15% | 224B |
-
|
-
|
-
|
- Stock Market
- Stocks
- AMGN Stock
- AMGN34 Stock
- Charts Amgen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
